Setting New
Standards for
Venous Care

Setting New
Standards for
Venous Care

What is Chronic Venous Insufficiency (CVI)?

Insufficient blood is returned to the heart and lungs due to damaged valves in the veins of the leg.

First-in-class surgical replacement venous valve for treatment of Chronic Venous Insufficiency (CVI) in the deep veins of the leg.

Patient Experience From Pivotal SAVVE® Trial

Initial Positive 6-Month Topline Efficacy Data From SAVVE Trial* 

  • 97% of all patients achieved Clinical Improvement (Improvement in rVCSS)

  • 74% of all patients achieved a Clinical Meaningful Benefit (≥ 3 point improvement in rVCSS)

  • 8 point average improvement in rVCSS
    More than two and a half times the amount needed to show Clinically Meaningful Benefit

  • The revised Venous Clinical Severity Score (rVCSS) is an objective grading system used by vascular specialists throughout the world to measure the severity of venous diseases

* 6-month data compared to baseline

Venous Ulcer Healing

Latest News

Stock Data

The VenoValve® and enVVe® are investigational medical devices currently in development. Neither device is approved or cleared for any indication in any market. The VenoValve® is only available for use in the United States in pre-market clinical studies.